Memory-enriched CAR-T Cells Immunotherapy for B Cell Lymphoma

NCT02652910 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Adult Diffuse Large Cell Lymphoma
Recurrent Follicular Lymphoma
Recurrent Mantle Cell Lymphoma
Stage III Adult Diffuse Large Cell Lymphoma
Stage III Follicular Lymphoma
Stage III Mantle Cell Lymphoma
Stage IV Adult Diffuse Large Cell Lymphoma
Stage IV Follicular Lymphoma
Stage IV Mantle Cell Lymphoma

Interventions

DRUG: CD19.CAR-T cells

Sponsor

Xinqiao Hospital of Chongqing

Collaborators

[object Object]
[object Object]
[object Object]